Work

Abstract B004: Belzutifan and lenvatinib mutually reshape renal cell carcinoma tumor microenvironment through the HIF-2A axis

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.kidney26-b004

Authors: Douglas Linn, Long Cui, Gustave Hebert, Eric Muise, Rodolfo Perini, Brian J. Long

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7135203346

Cites:

Cited by:

Related to: